Cargando…

Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma

BACKGROUND: Toll-like receptors (TLRs) recognize microbial and endogenous ligands and have already shown to play a role in esophageal cancer. In this study, we evaluated especially TLRs that sense bacterial cell wall components in Barrett's esophagus, dysplasia and esophageal adenocarcinoma. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Huhta, Heikki, Helminen, Olli, Lehenkari, Petri P., Saarnio, Juha, Karttunen, Tuomo J., Kauppila, Joonas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029654/
https://www.ncbi.nlm.nih.gov/pubmed/27008696
http://dx.doi.org/10.18632/oncotarget.8151
_version_ 1782454550473474048
author Huhta, Heikki
Helminen, Olli
Lehenkari, Petri P.
Saarnio, Juha
Karttunen, Tuomo J.
Kauppila, Joonas H.
author_facet Huhta, Heikki
Helminen, Olli
Lehenkari, Petri P.
Saarnio, Juha
Karttunen, Tuomo J.
Kauppila, Joonas H.
author_sort Huhta, Heikki
collection PubMed
description BACKGROUND: Toll-like receptors (TLRs) recognize microbial and endogenous ligands and have already shown to play a role in esophageal cancer. In this study, we evaluated especially TLRs that sense bacterial cell wall components in Barrett's esophagus, dysplasia and esophageal adenocarcinoma. METHODS: TLRs 1, 2, 4 and 6 were stained immunohistochemically and assessed in esophageal specimens from patients with esophageal dysplasia (n = 30) or adenocarcinoma (n = 99). Structures and lesions were evaluated including normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51) without dysplasia, and low-grade (n = 42) or high-grade dysplasia (n = 37), and esophageal adenocarcinoma (n = 99). RESULTS: We found TLR1, TLR2, TLR4 and TLR6 expression in all lesions. TLR expression increased in Barrett's mucosa and dysplasia. There was profound increase of TLR expression from gastric- to intestinal-type columnar epithelium. In cancers, high nuclear and cytoplasmic staining of TLR4 associated with metastatic disease and poor prognosis. CONCLUSIONS: TLR1, TLR2, TLR4 and TLR6 are upregulated during malignant changes of esophageal columnar epithelium. Increased TLR4 expression associates with advanced stage and poor prognosis in esophageal adenocarcinoma.
format Online
Article
Text
id pubmed-5029654
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50296542016-09-29 Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma Huhta, Heikki Helminen, Olli Lehenkari, Petri P. Saarnio, Juha Karttunen, Tuomo J. Kauppila, Joonas H. Oncotarget Research Paper BACKGROUND: Toll-like receptors (TLRs) recognize microbial and endogenous ligands and have already shown to play a role in esophageal cancer. In this study, we evaluated especially TLRs that sense bacterial cell wall components in Barrett's esophagus, dysplasia and esophageal adenocarcinoma. METHODS: TLRs 1, 2, 4 and 6 were stained immunohistochemically and assessed in esophageal specimens from patients with esophageal dysplasia (n = 30) or adenocarcinoma (n = 99). Structures and lesions were evaluated including normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51) without dysplasia, and low-grade (n = 42) or high-grade dysplasia (n = 37), and esophageal adenocarcinoma (n = 99). RESULTS: We found TLR1, TLR2, TLR4 and TLR6 expression in all lesions. TLR expression increased in Barrett's mucosa and dysplasia. There was profound increase of TLR expression from gastric- to intestinal-type columnar epithelium. In cancers, high nuclear and cytoplasmic staining of TLR4 associated with metastatic disease and poor prognosis. CONCLUSIONS: TLR1, TLR2, TLR4 and TLR6 are upregulated during malignant changes of esophageal columnar epithelium. Increased TLR4 expression associates with advanced stage and poor prognosis in esophageal adenocarcinoma. Impact Journals LLC 2016-03-17 /pmc/articles/PMC5029654/ /pubmed/27008696 http://dx.doi.org/10.18632/oncotarget.8151 Text en Copyright: © 2016 Huhta et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Huhta, Heikki
Helminen, Olli
Lehenkari, Petri P.
Saarnio, Juha
Karttunen, Tuomo J.
Kauppila, Joonas H.
Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
title Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
title_full Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
title_fullStr Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
title_full_unstemmed Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
title_short Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
title_sort toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029654/
https://www.ncbi.nlm.nih.gov/pubmed/27008696
http://dx.doi.org/10.18632/oncotarget.8151
work_keys_str_mv AT huhtaheikki tolllikereceptors124and6inesophagealepitheliumbarrettsesophagusdysplasiaandadenocarcinoma
AT helminenolli tolllikereceptors124and6inesophagealepitheliumbarrettsesophagusdysplasiaandadenocarcinoma
AT lehenkaripetrip tolllikereceptors124and6inesophagealepitheliumbarrettsesophagusdysplasiaandadenocarcinoma
AT saarniojuha tolllikereceptors124and6inesophagealepitheliumbarrettsesophagusdysplasiaandadenocarcinoma
AT karttunentuomoj tolllikereceptors124and6inesophagealepitheliumbarrettsesophagusdysplasiaandadenocarcinoma
AT kauppilajoonash tolllikereceptors124and6inesophagealepitheliumbarrettsesophagusdysplasiaandadenocarcinoma